Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

EXPert opinions

Commentaries on select publications


recent publications on COVID-19 & PSORIASIS

CONCLUSIONS: Systemic treatments for psoriasis (including biologics) were not associated with increased risk of in-hospital mortality due to COVID-19. These results support the maintain of systemic treatment for psoriasis during the pandemic.
Psoriasis is a chronic, immune-mediated inflammatory disease with heterogeneous clinical manifestations. Various trigger factors like infections and drugs are known to elicit or aggravate psoriasis. Previously, a possible association of vaccination and the new onset (particularly guttate lesions) or exacerbation of psoriasis has been reported.
No abstract


View all publications from PubMed 


We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.